RecruitingNCT04366804

International Validation of Two Non-motor Scales in PD (NFS and SPARK)

International Validation of Two Non-motor Scales in Parkinson's Disease: the Neuropsychiatric Fluctuations Scale (NFS) and the Shame in Parkinson's Disease (SPARK) Scale

Sponsor

Insel Gruppe AG, University Hospital Bern

Enrollment

300 participants

Start Date

Dec 3, 2020

Study Type

OBSERVATIONAL

Conditions

Parkinson's Disease Non-motor Symptoms

Summary

The goal of this project is to develop the international validation of two new rating scales, the Neuropsychiatric Fluctuations Scale (NFS) and the Shame in PARKinson's disease (SPARK) Scale, in order to improve the understanding of the extent and severity of non-motor symptoms in Parkinson's disease (PD).

Eligibility

Min Age: 30 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This study is testing two new assessment tools — the NFS and SPARK scales — to measure non-motor symptoms (things like sleep problems, mood changes, cognitive difficulties, and fatigue) in people with Parkinson's disease. The goal is to validate these scales across different languages and countries so they can be used worldwide in clinical care and research. **You may be eligible if:** - You have a confirmed diagnosis of Parkinson's disease - You are between 30 and 75 years old - You can communicate fluently in the language in which the assessments are offered - You have provided written informed consent **You may NOT be eligible if:** - You have Parkinson's-related dementia, defined as a score below 24 on the MoCA (Montreal Cognitive Assessment) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(8)

Centre hospitalier régional universitaire de Besançon

Besançon, France

Universitätsklinikum Carl Gustav Carus

Dresden, Germany

Aristotle University of Thessaloniki

Thessaloniki, Greece

Transilvania University

Brasov, Romania

Hospital Universitario Burgos

Burgos, Spain

Ruber International Hospital

Madrid, Spain

Insel Gruppe AG University Hospital Bern

Bern, Switzerland

King's College London

London, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04366804

Related Trials

Deep Brain Stimulation Therapy in Movement Disorders

NCT021196111 location

Auditory Sleep Stimulation or Sham in People With Parkinson Disease Mild Cognitive Impairment During Cognitive Training

NCT074419151 location